ABOUT SCILNQ
Built Around the Complexity of Antibody Development
Antibody therapeutics are built through a series of interconnected scientific, technical, regulatory, and clinical decisions. As programs advance, the expertise required to make those decisions evolves with them.
SciLnq was built to give antibody developers access to experienced professionals across critical stages of development, bringing specialized expertise into programs when and where it can have the greatest impact.
Our professionals work alongside sponsor teams, combining strategic guidance with hands-on execution to address immediate challenges, strengthen development decisions, and maintain program momentum.
By bringing together experienced professionals across antibody development, SciLnq helps sponsors access the expertise they need to move promising science toward viable therapies.
WHY SCILNQ EXISTS
Specialized Expertise for a Complex Development Path.
Antibody development requires specialized expertise that changes as a program advances. The scientific and technical challenges of early development give way to new regulatory, clinical, operational, and safety demands as promising candidates move toward the clinic.
Building every capability internally is not always practical, particularly when the expertise required today may differ from what a program needs tomorrow.
SciLnq exists to bridge those gaps, bringing experienced professionals into antibody programs at critical stages to strengthen decisions, provide hands-on execution, and help teams maintain momentum.
HOW WE WORK
Embedded. Experienced. Accountable.
SciLnq professionals work directly alongside sponsor teams, integrating into antibody programs with clear priorities, defined responsibilities, and accountability for execution.
Our model provides access to specialized expertise when and where it is needed, allowing sponsors to strengthen critical capabilities without the time, complexity, or long-term commitment of traditional hiring.
Rather than operating solely as outside advisors, our professionals become trusted members of the team, combining experienced guidance with hands-on execution to solve problems, strengthen programs, and move antibody development forward.
HOW WE PARTNER
Built to Work Alongside Your Team.
We align around your program.
Our professionals integrate around your priorities, development stage, and immediate needs, with clearly defined responsibilities and objectives.
We combine guidance with execution.
SciLnq professionals don't simply advise from the sidelines. They contribute directly to the work, helping teams solve problems, make informed decisions, and execute against critical priorities.
We evolve with your needs.
As antibody programs advance, priorities and expertise requirements change. Our flexible model allows support to evolve with your program, helping maintain continuity through critical stages of development.
WHO WE SUPPORT
Built for Companies Developing Antibody Therapeutics.
SciLnq partners with antibody developers navigating the scientific, technical, regulatory, and clinical challenges that emerge as programs advance from discovery toward the clinic.
We support organizations at critical stages of development, from emerging and venture-backed biotechs building their first programs to established companies advancing antibody pipelines.
Whether optimizing a candidate, preparing for IND-enabling development, advancing First-in-Human and early clinical studies, or strengthening the capabilities required for what comes next, SciLnq provides experienced professionals who work alongside your team.
Our model adapts to your program, stage of development, and evolving priorities, providing specialized expertise where it can have the greatest impact.
.jpg)
OUR COMMITMENT
Your Programs Success is Our Priority.
SciLnq is built around a simple principle: our success is measured by the success of the sponsors and programs we support.
Our professionals bring experienced judgment, clear communication, and accountability to every engagement, working alongside sponsor teams with a shared commitment to the program and its objectives.
Whether addressing an immediate challenge or supporting a critical stage of antibody development, our focus remains the same: provide the expertise, execution, and partnership needed to help your program succeed.